Physician profile
Daniel H Silcox
NPI 1952303992
$3,415,041.23
in general payments reported to CMS, 2019-2025
5 companies · $624K in 2025
The $624K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $502K · 2020: $379K · 2021: $339K · 2022: $393K · 2023: $578K · 2024: $600K · 2025: $624K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.7M · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $61K · Travel and Lodging: $5,101 · Consulting Fee: $4,347 · Food and Beverage: $783.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,730,723.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $60,697.50 |
| Travel and Lodging | $5,101.10 |
| Consulting Fee | $4,346.64 |
| Food and Beverage | $782.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,533,506.03 | 2021-2025 | Divergence Anterior Cervical Fusion System, Pivox Oblique Lateral Spinal System, Divergence-L Anterior/Oblique Lumbar Fusion System |
| Medtronic USA, INC. | $881,349.38 | 2019-2020 | |
| My01 INC. | $101.71 | 2024 | My01 Continuous Compartmental Pressure Monitor |
| Arteriocyte Medical Systems, INC. | $59.66 | 2024 | Magellan |
| Bioventus LLC | $24.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Silcox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.